ATE139998T1 - 2-substituierte-tertiäre-carbinolderivate als antivirale arzneimittel - Google Patents

2-substituierte-tertiäre-carbinolderivate als antivirale arzneimittel

Info

Publication number
ATE139998T1
ATE139998T1 AT93870060T AT93870060T ATE139998T1 AT E139998 T1 ATE139998 T1 AT E139998T1 AT 93870060 T AT93870060 T AT 93870060T AT 93870060 T AT93870060 T AT 93870060T AT E139998 T1 ATE139998 T1 AT E139998T1
Authority
AT
Austria
Prior art keywords
antiviral drugs
substituted tertiary
carbinol derivatives
tertiary carbinol
derivatives
Prior art date
Application number
AT93870060T
Other languages
English (en)
Inventor
Ish Kumar Khanna
Richard August Mueller
Richard Mathias Weier
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE139998T1 publication Critical patent/ATE139998T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
AT93870060T 1992-04-01 1993-03-31 2-substituierte-tertiäre-carbinolderivate als antivirale arzneimittel ATE139998T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/861,058 US5258518A (en) 1992-04-01 1992-04-01 2-substituted tertiary carbinol derivatives of deoxynojirimycin

Publications (1)

Publication Number Publication Date
ATE139998T1 true ATE139998T1 (de) 1996-07-15

Family

ID=25334759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93870060T ATE139998T1 (de) 1992-04-01 1993-03-31 2-substituierte-tertiäre-carbinolderivate als antivirale arzneimittel

Country Status (9)

Country Link
US (7) US5258518A (de)
EP (1) EP0566556B1 (de)
JP (1) JP3210772B2 (de)
AT (1) ATE139998T1 (de)
CA (1) CA2093078C (de)
DE (1) DE69303413T2 (de)
DK (1) DK0566556T3 (de)
ES (1) ES2090948T3 (de)
GR (1) GR3021228T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
DE69536015D1 (de) * 1995-03-30 2009-12-10 Pfizer Prod Inc Chinazolinone Derivate
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
PT1030839E (pt) 1997-11-10 2004-05-31 Searle & Co Utilizacao de iminoacucares para tratar a resistencia a multifarmacos
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
DE69932154T2 (de) 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
ATE402701T1 (de) 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
RU2152386C1 (ru) * 1999-05-27 2000-07-10 Российский Университет Дружбы Народов Способ получения 2,3,5,6-тетраоксо-4-нитропиридата аммония
CN101228173A (zh) * 2005-06-08 2008-07-23 阿米库斯治疗学公司 三氟甲磺酸酯化的化合物的稳定化
SI2027137T1 (sl) * 2005-06-08 2015-06-30 Amicus Therapeutics, Inc. Čiščenje imino in amino sladkorja
WO2006133447A1 (en) * 2005-06-08 2006-12-14 Amicus Therapeutics, Inc. Crystalline sugar compositions and method of making
JP6166150B2 (ja) * 2013-10-29 2017-07-19 アルプス電気株式会社 受光装置
EP3318277A1 (de) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitoren der glucosylceramidsynthase zur behandlung von motoneuronerkrankungen

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
DE2848117A1 (de) * 1978-11-06 1980-05-14 Bayer Ag Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
DE3620645A1 (de) * 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
EP0282618A1 (de) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin als Anti-HIV-Therapeutikum
JPS6461459A (en) * 1987-08-28 1989-03-08 Nippon Shinyaku Co Ltd Moranoline derivative
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus
US4861892A (en) * 1988-02-12 1989-08-29 G. D. Searle & Co. Method for synthesis of deoxymannojirimycin
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US4957926A (en) * 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
US5025021A (en) * 1989-07-27 1991-06-18 Monsanto Company 1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitors
ES2036512T3 (es) * 1989-07-27 1996-03-01 Monsanto Co Compuestos de piperidina con actividad inhibidora de las glicosidasas.
US5175168A (en) * 1989-07-27 1992-12-29 Monsanto Company Intermediates for 1,2-dideoxy-2-fluoronojirimycin
US5026713A (en) * 1989-08-29 1991-06-25 Monsanto Company 1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activity
US5218121A (en) * 1989-08-29 1993-06-08 Monsanto Company Synthesis of 1,3-dideoxy-3-fluoronojirimycin
US5130320A (en) * 1989-08-29 1992-07-14 Monsanto Company Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
DE4009561A1 (de) * 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
US5128347A (en) * 1990-10-18 1992-07-07 Monsanto Company Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars

Also Published As

Publication number Publication date
JPH06279408A (ja) 1994-10-04
US5502193A (en) 1996-03-26
US5530132A (en) 1996-06-25
ES2090948T3 (es) 1996-10-16
CA2093078C (en) 2005-02-22
EP0566556A1 (de) 1993-10-20
US5639882A (en) 1997-06-17
DK0566556T3 (da) 1996-08-19
GR3021228T3 (en) 1997-01-31
DE69303413D1 (de) 1996-08-08
US5637707A (en) 1997-06-10
JP3210772B2 (ja) 2001-09-17
CA2093078A1 (en) 1993-10-02
DE69303413T2 (de) 1997-01-09
US5258518A (en) 1993-11-02
US5350854A (en) 1994-09-27
EP0566556B1 (de) 1996-07-03
US5523406A (en) 1996-06-04

Similar Documents

Publication Publication Date Title
ATE139998T1 (de) 2-substituierte-tertiäre-carbinolderivate als antivirale arzneimittel
ATE88998T1 (de) Benzodiazepin-derivate und diese enthaltende arzneimittel.
ATE183182T1 (de) S-triazinderivate als lichtschutzmittel
DK256890D0 (da) Benzo-piperidin-, -piperidyliden- og piperazinforbindelser, kompositioner indeholdende forbindelserne og fremgangsmaader til forbindelsernes fremstilling og anvendelse
DE69326369D1 (de) 14-Beta-Hydroxy-10-Deacetyl-Baccatin-III und seine Derivate als Antitumormittel
FI956248A7 (fi) Uusia välituotteita antihistamiinisten 4-difenyylimetyyli/difenyylimetoksipiperidiinijohdannaisten valmistusta varten
DK0776324T3 (da) Endothelin-antagonister
FR2723091B1 (fr) Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
NO931482L (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
ATE247104T1 (de) Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren
ATE107308T1 (de) Mevalonolactone vom thienopyridin-typ.
DE69016571D1 (de) 1,4-Dideoxy-1,4-imino-D-mannitol-Derivate.
DK0736009T3 (da) N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
DE69227207D1 (de) 1-Piperazinyl-2-butene und 2-butyne, Zwischenverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69113893D1 (de) 6,7-Disubstituierte 2-Aminotetraline als Immunomodulatoren und pharmazeutische Zusammensetzungen davon.
NO303829B1 (no) Nye benzylalkoholderivater, mellomprodukter, farmas°ytiske preparater inneholdende de nye forbindelsene samt deres anvendelse
DE69304393D1 (de) 2- und 3-Amino und Azidoderivate von 1,5-Iminozuckern als antivirale Arzneimittel
AU4843093A (en) Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin)
DK656889D0 (da) Hidtil ukendte forbindelser
DE59505063D1 (de) Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0527298T3 (da) Fremgangsmåde til fremstilling af pipazetate
ATE187331T1 (de) Benzopyranderivate

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee